Physician profile
Joyce E Turner
NPI 1851502629
$4,642.56
in general payments reported to CMS, 2019-2025
10 companies · $868 in 2025
The $868 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $122 · 2023: $1,726 · 2024: $1,805 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,398.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,870.38 | 2023-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $570.85 | 2023-2024 | Caplyta |
| Glaxosmithkline, LLC. | $561.32 | 2021-2025 | Benlysta |
| Neurocrine Biosciences, INC. | $199.01 | 2023-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $140.47 | 2024 | Rexulti |
| Lilly USA, LLC | $124.99 | 2024 | Mounjaro |
| Novo Nordisk INC | $121.86 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.54 | 2023 | Invega Sustenna |
| Exact Sciences Corporation | $18.32 | 2025 | The Cologuard Plus Collection Kit |
| Scilex Pharmaceuticals INC. | $15.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.